Literature DB >> 22236892

Thoracic manifestations of collagen vascular diseases.

Julia Capobianco1, Alexandre Grimberg, Bruna M Thompson, Viviane B Antunes, Dany Jasinowodolinski, Gustavo S P Meirelles.   

Abstract

Collagen vascular diseases are a diverse group of immunologically mediated systemic disorders that often lead to thoracic changes. The collagen vascular diseases that most commonly involve the lung are rheumatoid arthritis, progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and dermatomyositis, mixed connective tissue disease, and Sjögren syndrome. Interstitial lung disease and pulmonary arterial hypertension are the main causes of mortality and morbidity among patients with collagen vascular diseases. Given the broad spectrum of possible thoracic manifestations and the varying frequency with which different interstitial lung diseases occur, the interpretation of thoracic images obtained in patients with collagen vascular diseases can be challenging. The task may be more difficult in the presence of treatment-related complications such as drug toxicity and infections, which are common in this group of patients. Although chest radiography is most often used for screening and monitoring of thoracic alterations, high-resolution computed tomography can provide additional information about lung involvement in collagen vascular diseases and may be especially helpful for differentiating specific disease patterns in the lung. General knowledge about the manifestations of thoracic involvement in collagen vascular diseases allows radiologists to provide better guidance for treatment and follow-up of these patients. © RSNA, 2012.

Entities:  

Mesh:

Year:  2012        PMID: 22236892     DOI: 10.1148/rg.321105058

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  13 in total

Review 1.  The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin.

Authors:  Casey T Weaver; Charles O Elson; Lynette A Fouser; Jay K Kolls
Journal:  Annu Rev Pathol       Date:  2012-11-15       Impact factor: 23.472

Review 2.  [Pulmonary fibrosis in rheumatic diseases].

Authors:  D Grund; E Siegert
Journal:  Internist (Berl)       Date:  2018-09       Impact factor: 0.743

3.  [Pulmonary manifestations of connective tissue diseases].

Authors:  B Rehbock
Journal:  Radiologe       Date:  2015-03       Impact factor: 0.635

Review 4.  Intra-thoracic rheumatoid arthritis: Imaging spectrum of typical findings and treatment related complications.

Authors:  Thanissara Chansakul; Paul F Dellaripa; Tracy J Doyle; Rachna Madan
Journal:  Eur J Radiol       Date:  2015-07-17       Impact factor: 3.528

Review 5.  [Pulmonary fibrosis in rheumatic diseases].

Authors:  D Grund; E Siegert
Journal:  Z Rheumatol       Date:  2016-10       Impact factor: 1.372

Review 6.  Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF).

Authors:  Adelle S Jee; Stephen Adelstein; Jane Bleasel; Gregory J Keir; MaiAnh Nguyen; Joanne Sahhar; Peter Youssef; Tamera J Corte
Journal:  J Clin Med       Date:  2017-05-04       Impact factor: 4.241

7.  Imaging of Thoracic Wall Abnormalities.

Authors:  Alexandre Semionov; John Kosiuk; Amr Ajlan; Federico Discepola
Journal:  Korean J Radiol       Date:  2019-10       Impact factor: 3.500

Review 8.  Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment.

Authors:  George E Fragoulis; Elena Nikiphorou; Jörg Larsen; Peter Korsten; Richard Conway
Journal:  Front Med (Lausanne)       Date:  2019-10-23

9.  Histologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis.

Authors:  Ho Cheol Kim; Joon Seon Song; Sojung Park; Hee-Young Yoon; So Yun Lim; Eun Jin Chae; Se Jin Jang; Jin Woo Song
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

Review 10.  [Pulmonary manifestations in collagen vascular diseases].

Authors:  M N A Vogel; M Kreuter; H-U Kauczor; C-P Heußel
Journal:  Radiologe       Date:  2016-10       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.